IFP Advisors’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
IFP Advisors's PBYI Position: Q3 2026 in Review
IFP Advisors increased its Puma Biotechnology (PBYI) stake by 20% in Q3 2026, buying an estimated $14.1K and bringing the position to 9,470 shares worth $94K. The position accounts for ﹤0.01% of the portfolio, ranked #2011.
IFP Advisors first reported a position in PBYI in Q4 2017 and has held it in 15 quarters since. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- IFP Advisors held 9,470 shares of Puma Biotechnology worth $94K as of Q3 2026.
- IFP Advisors bought 1,607 Puma Biotechnology shares in Q3 2026, an estimated $14.1K.
- Puma Biotechnology made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #2011 holding.
- IFP Advisors first reported a position in Puma Biotechnology in Q4 2017 and has held it in 15 quarters since.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.